Fighting Blindness Canada research

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet...

Read More
Fighting Blindness Canada

New Treatment Target for AMD Identified

For people living with wet age-related macular degeneration (AMD), the first line of treatment is anti-VEGF injections Anti-VEGF injections have...

Read More